AI Health Startup Iterative Scopes Raises $30 Mln in Series A Funding Round

By Nicholas Say Nicholas Say has been verified by Muck Rack's editorial team
Published on August 4, 2021

Iterative Scopes, a Massachusetts-based AI Health startup, raised $30 million in Series A funding to apply the potential of AI to gastroenterology.

The round was led by Obvious Ventures and counted with the participation of Eli Lilly, Johnson & Johnson Innovation, Breyer Capital, and Seae Ventures, as well as angel investors like Lee Shapiro, Zach Weinberg, and Nat Turner. The round brings the startup’s total funding to $43.5 million since its founding in 2017.

Lotus Mallbris, M.D., Ph.D., Vice President of Immunology Development at Eli Lilly, and Nan Li, Managing Director at Obvious Ventures, will be joining Iterative Scopes’ board of directors. Mallbris referred to the firm’s decision to invest in the startup by stating:

“Iterative Scopes has an interlocking portfolio of talented people, great ideas, solid results, promising alliances, and an advisory board of outstanding experts. We are confident that we will be able to use what is being built here to improve the efficiency of how we conduct clinical trials, which may allow much-needed medicines to get to our patients faster.”

The startup started as a spinout of the Massachusetts Institute of Technology (MIT) aimed to use AI to identify the best treatment and course of action for patients suffering from gastrointestinal diseases. This application will allow physicians to make better decisions by using computer vision algorithms to improve their clinical workflow. Jonathan Ng, CEO & founder of Iterative Scopes, referred to this approach by saying:

“These technologies also have the potential for biopharmaceutical companies to solve some of the most vexing challenges of GI clinical trials. We believe that the most successful healthcare technologies will be able to connect the dots between patient, provider, payer, and pharma, and we are excited to be at the very forefront of this movement in gastroenterology,”

While AI technology has gained adoption in the health industry, gastroenterology has seen fewer benefits when compared to areas like oncology and infectious diseases. The AI health startup believes that AI can replace the clinical-intuition approach gastroenterology has used over the past centuries, revolutionizing the medical branch.

By Nicholas Say Nicholas Say has been verified by Muck Rack's editorial team

Nicholas Ross Say is a news desk editor at Grit Daily. An award-winning journalist, he covers the daily startup beat. He grew up in Ann Arbor, Michigan and has lived in South America and South East Asia. At present, Nicholas lives in Southern Vietnam where the Sun shines, and the noodles flow like wine. He's written for Blockonomi and Coin Journal, among others.

Read more

More articles by Nicholas Say


Nicholas Say Nicholas Say has been verified by Muck Rack's editorial team
on September 12, 2021

Genetics Startup iECURE Closes $50 mln Series A Funding Round

social media
Nicholas Say Nicholas Say has been verified by Muck Rack's editorial team
on September 12, 2021

Bipartisan Social Media Platform Developed By Students Launch Beta Version

Nicholas Say Nicholas Say has been verified by Muck Rack's editorial team
on September 12, 2021

Robotics Startup Agile Robots Secures $220 mln in Funding

Nicholas Say Nicholas Say has been verified by Muck Rack's editorial team
on September 12, 2021

GreenTech Startup Solugen Closes $350 mln Series C Financing Round

Nicholas Say Nicholas Say has been verified by Muck Rack's editorial team
on September 11, 2021

Nutrition Startup Teatis Closes $1 mln Seed Funding Round

Nicholas Say Nicholas Say has been verified by Muck Rack's editorial team
on September 11, 2021

Education Startup Leap Secures $55 mln In Series C Funding

More GD News